|
1
|
Ball L, Dameri M and Pelosi P: Modes of
mechanical ventilation for the operating room. Best Practice and
Research Clinical Anaesthesiology. 29. Elsevier; Amsterdam: pp.
285–299. 2015, PubMed/NCBI
|
|
2
|
Hartmann EK, Boehme S, Bentley A, Duenges
B, Klein KU, Elsaesser A, Baumgardner JE, David M and Markstaller
K: Influence of respiratory rate and end-expiratory pressure
variation on cyclic alveolar recruitment in an experimental lung
injury model. Crit Care. 16:R82012.PubMed/NCBI
|
|
3
|
Rocco PR, Dos Santos C and Pelosi P:
Pathophysiology of ventilator-associated lung injury. Curr Opin
Anaesthesiol. 25:123–130. 2012.PubMed/NCBI
|
|
4
|
Usatyuk PV and Natarajan V:
Hydroxyalkenals and oxidized phospholipids modulation of
endothelial cytoskeleton, focal adhesion and adherens junction
proteins in regulating endothelial barrier function. Microvasc Res.
83:45–55. 2012.PubMed/NCBI
|
|
5
|
Frank JA, Parsons PE and Matthay MA:
Pathogenetic significance of biological markers of
ventilator-associated lung injury in experimental and clinical
studies. Chest. 130:1906–1914. 2006.PubMed/NCBI
|
|
6
|
Scheiermann J and Klinman DM: Suppressive
oligonucleotides inhibit inflammation in a murine model of
mechanical ventilator induced lung injury. J Thorac Dis.
8:2434–2443. 2016.PubMed/NCBI
|
|
7
|
Ko YA, Yang MC, Huang HT, Hsu CM and Chen
LW: NF-κB activation in myeloid cells mediates ventilator-induced
lung injury. Respir Res. 14:692013.PubMed/NCBI
|
|
8
|
Dent BT, Aarnes TK, Wavreille VA, Lakritz
J, Lerche P, KuKanich B, Riccó Pereira CH and Bednarski RM:
Pharmacokinetics and pharmacodynamic effects of oral transmucosal
and intravenous administration of dexmedetomidine in dogs. Am J Vet
Res. 80:969–975. 2019.PubMed/NCBI
|
|
9
|
Ma D, Hossain M, Rajakumaraswamy N, Arshad
M, Sanders RD, Franks NP and Maze M: Dexmedetomidine produces its
neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J
Pharmacol. 502:87–97. 2004.PubMed/NCBI
|
|
10
|
Taniguchi T, Kurita A, Kobayashi K,
Yamamoto K and Inaba H: Dose- and time-related effects of
dexmedetomidine on mortality and inflammatory responses to
endotoxin-induced shock in rats. J Anesth. 22:221–228.
2008.PubMed/NCBI
|
|
11
|
Chen C, Zhang Z, Chen K, Zhang F, Peng M
and Wang Y: Dexmedetomidine regulates inflammatory molecules
contributing to ventilator-induced lung injury in dogs. J Surg Res.
187:211–218. 2014.PubMed/NCBI
|
|
12
|
Chen H, Sun X, Yang X, Hou Y, Yu X, Wang
Y, Wu J, Liu D, Wang H, Yu J, et al: Dexmedetomidine reduces
ventilator-induced lung injury (VILI) by inhibiting Toll-like
receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway. Bosn J
Basic Med Sci. 18:162–169. 2018.PubMed/NCBI
|
|
13
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002.PubMed/NCBI
|
|
14
|
Gong G, Yuan L, Cai L, Ran M, Zhang Y,
Gong H, Dai X, Wu W and Dong H: Tetramethylpyrazine suppresses
transient oxygen-glucose deprivation-induced connexin32 expression
and cell apoptosis via the ERK1/2 and p38 MAPK pathway in cultured
hippocampal neurons. PLoS One. 9:e1059442014.PubMed/NCBI
|
|
15
|
Zhang L, Jiang B, Zhu N, Tao M, Jun Y,
Chen X, Wang Q and Luo C: Mitotic checkpoint kinase Mps1/TTK
predicts prognosis of colon cancer patients and regulates tumor
proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt
pathway. Med Oncol. 37:52019.PubMed/NCBI
|
|
16
|
Long ME, Gong KQ, Eddy WE, Volk JS,
Morrell ED, Mikacenic C, West TE, Skerrett SJ, Charron J, Liles WC,
et al: MEK1 regulates pulmonary macrophage inflammatory responses
and resolution of acute lung injury. JCI Insight.
4:e1323772019.
|
|
17
|
Goyagi T and Tobe Y: Dexmedetomidine
improves the histological and neurological outcomes 48 h after
transient spinal ischemia in rats. Brain Res. 1566:24–30.
2014.PubMed/NCBI
|
|
18
|
Sanders RD, Giombini M, Ma D, Ohashi Y,
Hossain M, Fujinaga M and Maze M: Dexmedetomidine exerts
dose-dependent age-independent antinociception but age-dependent
hypnosis in Fischer rats. Anesth Analg. 100:1295–1302.
2005.PubMed/NCBI
|
|
19
|
Gao Y, Zhou S, Wang F, Zhou Y, Sheng S, Qi
D, Huang JH, Wu E, Lv Y and Huo X: Hepatoprotective effects of limb
ischemic post-conditioning in hepatic ischemic rat model and liver
cancer patients via PI3K/ERK pathways. Int J Biol Sci.
14:2037–2050. 2018.PubMed/NCBI
|
|
20
|
Li LF, Liao SK, Ko YS, Lee CH and Quinn
DA: Hyperoxia increases ventilator-induced lung injury via
mitogen-activated protein kinases: A prospective, controlled animal
experiment. Crit Care. 11:R252007.PubMed/NCBI
|
|
21
|
Sammons MJ, Raval P, Davey PT, Rogers D,
Parsons AA and Bingham S: Carrageenan-induced thermal hyperalgesia
in the mouse: Role of nerve growth factor and the mitogen-activated
protein kinase pathway. Brain Res. 876:48–54. 2000.PubMed/NCBI
|
|
22
|
Biehl M, Kashiouris MG and Gajic O:
Ventilator-induced lung injury: Minimizing its impact in patients
with or at risk for ARDS. Respir Care. 58:927–937. 2013.PubMed/NCBI
|
|
23
|
Cortjens B, Royakkers AA, Determann RM,
van Suijlen JD, Kamphuis SS, Foppen J, de Boer A, Wieland CW,
Spronk PE, Schultz MJ, et al: Lung-protective mechanical
ventilation does not protect against acute kidney injury in
patients without lung injury at onset of mechanical ventilation. J
Crit Care. 27:261–267. 2012.PubMed/NCBI
|
|
24
|
Ye L, Zeng Q, Dai H, Zhang W, Wang X, Ma
R, Hong X, Zhao C and Pan L: Endoplasmic reticulum stress is
involved in ventilator-induced lung injury in mice via the
IRE1α-TRAF2-NF-κB pathway. Int Immunopharmacol.
78:1060692020.PubMed/NCBI
|
|
25
|
Cruickshank M, Henderson L, MacLennan G,
Fraser C, Campbell M, Blackwood B, Gordon A and Brazzelli M:
Alpha-2 agonists for sedation of mechanically ventilated adults in
intensive care units: a systematic review. Health Technol Assess.
20:v–xx, 1–117. 2016.PubMed/NCBI
|
|
26
|
Shehabi Y, Howe BD, Bellomo R, Arabi YM,
Bailey M, Bass FE, Bin Kadiman S, McArthur CJ, Murray L, Reade MC,
et al ANZICS Clinical Trials Group and the SPICE III investigators,
: Early sedation with dexmedetomidine in critically ill patients. N
Engl J Med. 380:2506–2517. 2019.PubMed/NCBI
|
|
27
|
Gao J, Sun Z, Xiao Z, Du Q, Niu X, Wang G,
Chang YW, Sun Y, Sun W, Lin A, et al: Dexmedetomidine modulates
neuroinflammation and improves outcome via alpha2-adrenergic
receptor signaling after rat spinal cord injury. Br J Anaesth.
123:827–838. 2019.PubMed/NCBI
|
|
28
|
Cheng F, Yan FF, Liu YP, Cong Y, Sun KF
and He XM: Dexmedetomidine inhibits the NF-κB pathway and NLRP3
inflammasome to attenuate papain-induced osteoarthritis in rats.
Pharm Biol. 57:649–659. 2019.PubMed/NCBI
|
|
29
|
Zhou XY, Liu J, Xu ZP, Fu Q, Wang PQ and
Zhang HA: Dexmedetomidine inhibits the
lipopolysaccharide-stimulated inflammatory response in microglia
through the pathway involving TLR4 and NF-κB. Kaohsiung J Med Sci.
35:750–756. 2019.PubMed/NCBI
|
|
30
|
Xie Y, Guo C, Liu Y, Shi L and Yu J:
Dexmedetomidine activates the PI3K/Akt pathway to inhibit
hepatocyte apoptosis in rats with obstructive jaundice. Exp Ther
Med. 18:4461–4466. 2019.PubMed/NCBI
|
|
31
|
Zhai M, Liu C, Li Y, Zhang P, Yu Z, Zhu H,
Zhang L, Zhang Q and Wang J and Wang J: Dexmedetomidine inhibits
neuronal apoptosis by inducing Sigma-1 receptor signaling in
cerebral ischemia-reperfusion injury. Aging (Albany NY).
11:9556–9568. 2019.PubMed/NCBI
|
|
32
|
Sun J, Zheng S, Yang N, Chen B, He G and
Zhu T: Dexmedetomidine inhibits apoptosis and expression of COX-2
induced by lipopolysaccharide in primary human alveolar epithelial
type 2 cells. Biochem Biophys Res Commun. 517:89–95.
2019.PubMed/NCBI
|
|
33
|
Cui J, Zhao H, Wang C, Sun JJ, Lu K and Ma
D: Dexmedetomidine attenuates oxidative stress induced lung
alveolar epithelial cell apoptosis in vitro. Oxid Med Cell Longev.
2015:3583962015.PubMed/NCBI
|
|
34
|
Shi Y, Peng XH, Li X, Luo GP and Wu MF:
Neuroprotective role of dexmedetomidine pretreatment in cerebral
ischemia injury via ADRA2A-mediated phosphorylation of ERK1/2 in
adult rats. Exp Ther Med. 16:5201–5209. 2018.PubMed/NCBI
|
|
35
|
Qiu Z, Lu P, Wang K, Zhao X, Li Q, Wen J,
Zhang H, Li R, Wei H, Lv Y, et al: Dexmedetomidine inhibits
neuroinflammation by altering microglial M1/M2 polarization through
MAPK/ERK pathway. Neurochem Res. 45:345–353. 2020.PubMed/NCBI
|
|
36
|
Jin H and Yu J: Lidocaine protects H9c2
cells from hypoxia-induced injury through regulation of the
MAPK/ERK/NF-κB signaling pathway. Exp Ther Med. 18:4125–4131.
2019.PubMed/NCBI
|
|
37
|
Shen Q, Ma X, Hua Y, Chen M, Wang Y, Zhou
Q, Ye W and Zhu X: Aquaporin 3 expression induced by salvia
miltiorrhiza via ERK1/2 signal pathway in the primary human amnion
epithelium cells from isolated oligohydramnios. Curr Mol Med.
16:312–319. 2016.PubMed/NCBI
|
|
38
|
Sweeney TE, Lofgren S, Khatri P and Rogers
AJ: Gene expression analysis to assess the relevance of rodent
models to human lung injury. Am J Respir Cell Mol Biol. 57:184–192.
2017.PubMed/NCBI
|
|
39
|
Caunt CJ, Sale MJ, Smith PD and Cook SJ:
MEK1 and MEK2 inhibitors and cancer therapy: The long and winding
road. Nat Rev Cancer. 15:577–592. 2015.PubMed/NCBI
|
|
40
|
Dudley DT, Pang L, Decker SJ, Bridges AJ
and Saltiel AR: A synthetic inhibitor of the mitogen-activated
protein kinase cascade. Proc Natl Acad Sci USA. 92:7686–7689.
1995.PubMed/NCBI
|
|
41
|
Chen Y, Zhang H, Liu E, Xu CB and Zhang Y:
Homocysteine regulates endothelin type B receptors in vascular
smooth muscle cells. Vascul Pharmacol. 87:100–109. 2016.PubMed/NCBI
|
